Market Overview:
The global aflibercept drug market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of eye diseases and cancer, and the rising demand for aflibercept drugs in emerging markets. The global aflibercept drug market is segmented on the basis of type, application, and region. On the basis of type, it is divided into prefilled syringes package and vial packages. By application, it is classified into eye diseases (such as age-related macular degeneration [AMD], diabetic retinopathy) and cancer (such as breast cancer, colorectal cancer). Geographically, it is analyzed across North America (the U.S., Canada), Latin America (Mexico), Europe (Germany, France), Asia Pacific (China Japan India Australia South Korea Thailand Vietnam Indonesia Malaysia Philippines Singapore Taiwan Hong Kong Macau) Middle East & Africa(South Africa Saudi Arabia UAE Qatar Bahrain Kuwait Oman Jordan).
Product Definition:
Aflibercept is a drug used to treat cancer. It is used to help keep new blood vessels from forming in tumors. This may help keep the tumor from growing or spreading.
Prefilled Syring Package:
Prefilled syring packages are used to fill the pre-filled syringes. The drug is dissolved or suspended in the package and then it is sealed. The finished product can be immediately used for injection purposes or can be stored until it is needed for further use. These packages are available with a variety of technologies including vacuum, pressurized, and hot melt technology among others; which determine their application areas in pharmaceutical industries.
Vial Package:
Vial package is the primary packaging unit for pharmaceutical products. It contains the product in its pure form and protects it from contamination. Vials are glass or plastic bottles that contain a sterile solution that can be used to fill medical prescriptions as well as deliver vaccines directly to patients. The vial package also helps in containing any leakage of drug during shipment and storage, thus maintaining its quality and potency until the product is used.
Application Insights:
Cancer segment dominated the overall market in terms of revenue share in 2017. The high prevalence of cancer and increasing number of deaths due to cancer is anticipated to be a major factor for Aflibercept drug market growth. According to WHO, it is estimated that globally 1 in 6 people will develop cancer during their lifetime and around 2.4 million people are diagnosed with the disease every year which leads to death.
The eye disease segment is expected register the fastest CAGR from 2018 to 2030 owingto an increase in ophthalmic surgeries coupled with rising awareness about blindness caused by retinal diseases such as macular degeneration, diabetic retinopathy and cataract extraction surgery which can be treated using Aflibercept drug implant surgeries.
Regional Analysis:
North America dominated the global market in 2017 owing to high R&D investments and commercialization of new products. The region is expected to maintain its dominance over the forecast period due to increasing prevalence of ophthalmic disorders coupled with growing geriatric population. Moreover, high adoption rate of prefilled syringes for subcutaneous injection is also one of the major factors contributing toward regional growth.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to rising healthcare expenditure by governments and private sectors in developing economies such as India and China. In addition, increasing disposable income levels will also boost product demand in this region over the next eight years. Furthermore, a large number of people suffering from eye diseases are driving market growth in countries such as Japan, South Korea, Singapore etc., thus making APAC an attractive destination for global players operating within this space (i-to-in pharmaceutical companies).
Growth Factors:
- Increasing incidence of eye diseases and disorders: The increasing incidence of eye diseases and disorders is one of the key growth drivers for the aflibercept drug market. This is because aflibercept drugs are used to treat various ocular conditions such as age-related macular degeneration, diabetic retinopathy, and others.
- Rising demand for better treatment options: The rising demand for better treatment options is another key growth driver for the aflibercept drug market. This is because patients are increasingly becoming aware about the benefits of aflibercept drugs over traditional treatments and are demanding these drugs from healthcare providers.
- Growing number of approvals by regulatory authorities: The growing number of approvals by regulatory authorities is another key growth driver for the aflibercept drug market. This is because it indicates that more healthcare providers are recognizing the benefits offered by these drugs and are prescribing them to their patients accordingly.
Scope Of The Report
Report Attributes
Report Details
Report Title
Aflibercept Drug Market Research Report
By Type
Prefilled Syring Package, Vial Package
By Application
Eye Disease, Cancer
By Companies
Regeneron, Bayer, Sanofi, Regeneron
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
219
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Aflibercept Drug Market Report Segments:
The global Aflibercept Drug market is segmented on the basis of:
Types
Prefilled Syring Package, Vial Package
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Eye Disease, Cancer
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Regeneron
- Bayer
- Sanofi
- Regeneron
Highlights of The Aflibercept Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Prefilled Syring Package
- Vial Package
- By Application:
- Eye Disease
- Cancer
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Aflibercept Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Aflibercept is a drug that is used to treat macular degeneration.
Some of the major companies in the aflibercept drug market are Regeneron, Bayer, Sanofi, Regeneron.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Aflibercept Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Aflibercept Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Aflibercept Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Aflibercept Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Aflibercept Drug Market Size & Forecast, 2018-2028
4.5.1 Aflibercept Drug Market Size and Y-o-Y Growth
4.5.2 Aflibercept Drug Market Absolute $ Opportunity
Chapter 5 Global Aflibercept Drug Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Aflibercept Drug Market Size Forecast by Type
5.2.1 Prefilled Syring Package
5.2.2 Vial Package
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Aflibercept Drug Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Aflibercept Drug Market Size Forecast by Applications
6.2.1 Eye Disease
6.2.2 Cancer
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Aflibercept Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Aflibercept Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Aflibercept Drug Analysis and Forecast
9.1 Introduction
9.2 North America Aflibercept Drug Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Aflibercept Drug Market Size Forecast by Type
9.6.1 Prefilled Syring Package
9.6.2 Vial Package
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Aflibercept Drug Market Size Forecast by Applications
9.10.1 Eye Disease
9.10.2 Cancer
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Aflibercept Drug Analysis and Forecast
10.1 Introduction
10.2 Europe Aflibercept Drug Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Aflibercept Drug Market Size Forecast by Type
10.6.1 Prefilled Syring Package
10.6.2 Vial Package
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Aflibercept Drug Market Size Forecast by Applications
10.10.1 Eye Disease
10.10.2 Cancer
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Aflibercept Drug Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Aflibercept Drug Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Aflibercept Drug Market Size Forecast by Type
11.6.1 Prefilled Syring Package
11.6.2 Vial Package
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Aflibercept Drug Market Size Forecast by Applications
11.10.1 Eye Disease
11.10.2 Cancer
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Aflibercept Drug Analysis and Forecast
12.1 Introduction
12.2 Latin America Aflibercept Drug Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Aflibercept Drug Market Size Forecast by Type
12.6.1 Prefilled Syring Package
12.6.2 Vial Package
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Aflibercept Drug Market Size Forecast by Applications
12.10.1 Eye Disease
12.10.2 Cancer
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Aflibercept Drug Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Aflibercept Drug Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Aflibercept Drug Market Size Forecast by Type
13.6.1 Prefilled Syring Package
13.6.2 Vial Package
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Aflibercept Drug Market Size Forecast by Applications
13.10.1 Eye Disease
13.10.2 Cancer
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Aflibercept Drug Market: Competitive Dashboard
14.2 Global Aflibercept Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Regeneron
14.3.2 Bayer
14.3.3 Sanofi
14.3.4 Regeneron
